On Sept. 15, the House E&C Health Subcommittee held a hearing on H.R. 3164.
House Judiciary Committee Holds Hearing on Medicines and Intellectual Property
On May 21, the House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet held a hearing titled: “Medicines and IP: Balancing Innovation and Access.” The hearing examined policies and issues around the United States patent system, generic and biosimilar drug competition under the Hatch-Waxman Act, and maintaining domestic innovation in the drug development space.
Related
AMCP’s comments focus on provisions in the Proposed Rule that affect prescription drug payment and access to clinically appropriate therapies. AMCP has an interest in ensuring that Medicare payment and coverage policies promote transparency, control prices, preserve beneficiary access, and avoid fragmented incentives across care settings and benefit designs. AMCP encourages CMS to provide clear methodological explanations and monitor effects on beneficiary access and provider behavior.
On Aug. 28, AMCP responded to Senate HELP Chairman Bill Cassidy's 340B reform proposal.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
